candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]

RxCUI: 805863
RxNorm name: candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]
Display name: candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]
Full name: candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ATACAND HCT	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	ANI Pharmaceuticals, Inc.	d91152c4-66ba-466f-b4f9-0da628d42b1d	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 805863

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d91152c4-66ba-466f-b4f9-0da628d42b1d	candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]	SY	4	ATACAND HCT ® 16-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE	20251222
d91152c4-66ba-466f-b4f9-0da628d42b1d	candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]	SBD	4	ATACAND HCT ® 16-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE	20251222
d91152c4-66ba-466f-b4f9-0da628d42b1d	Atacand HCT 16 MG / 12.5 MG Oral Tablet	PSN	4	ATACAND HCT ® 16-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE	20251222
d91152c4-66ba-466f-b4f9-0da628d42b1d	Atacand HCT 16/12.5 Oral Tablet	SY	4	ATACAND HCT ® 16-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-12.5 ( candesartan cilexetil-hydrochlorothiazide ) TABLETS, FOR ORAL USE ATACAND HCT ® 32-25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE	20251222
8e50e65d-b79b-46b4-a147-796cb19f1407	Atacand HCT 16/12.5 Oral Tablet	SY	2	ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide	20120202
8e50e65d-b79b-46b4-a147-796cb19f1407	candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]	SBD	2	ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide	20120202
8e50e65d-b79b-46b4-a147-796cb19f1407	candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]	SY	2	ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide	20120202
8e50e65d-b79b-46b4-a147-796cb19f1407	Atacand HCT 16 MG / 12.5 MG Oral Tablet	PSN	2	ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide	20120202